PD-L1 is an IFNγ-independent maturation marker on tumor-associated macrophages and associates with good clinical outcome in human breast cancer

ER+ breast cancer is an immune cold cancer. We utilized single-cell RNA-sequencing to learn the cell heterogeneity in ER+ breast tumor microenvironment. 4 primary ER+ breast tumors were collected and analyzed by single-cell RNA sequencing.